Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2000;31:2460-2465

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quan, L.
Right arrow Articles by Khurana, V. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quan, L.
Right arrow Articles by Khurana, V. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*2-AMINOPYRIDINE
*4-AMINOPYRIDINE
Related Collections
Right arrow Animal models of human disease
Right arrow Ion channels/membrane transport
Right arrow Brain Circulation and Metabolism
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrow Pathology of Stroke

(Stroke. 2000;31:2460.)
© 2000 American Heart Association, Inc.


Original Contributions

Selective Effects of Subarachnoid Hemorrhage on Cerebral Vascular Responses to 4-Aminopyridine in Rats

Lilly Quan, BSc(Hons) Christopher G. Sobey, PhD

From the Department of Pharmacology, University of Melbourne, Parkville, Victoria, Australia.

Correspondence to Christopher G. Sobey, PhD, Department of Pharmacology, University of Melbourne, Parkville, Victoria 3010, Australia. E-mail c.sobey{at}pharmacology.unimelb.edu.au

Background and Purpose—We postulated that some abnormalities in cerebrovascular function after subarachnoid hemorrhage (SAH) may involve underlying alterations in K+ channel function. Thus, using pharmacological inhibitors, we assessed the influence of SAH on function of 2 types of K+ channel in regulation of basilar artery diameter in vivo and membrane potential (Em) in vitro.

Methods—Rats were injected with saline (control) or autologous blood (SAH) into the cisterna magna. Two days later, effects of vasoactive drugs on the basilar artery were examined with a cranial window preparation. Vascular responses to 4-aminopyridine (4-AP), 3-aminopyridine (3-AP), tetraethylammonium (TEA), serotonin, acetylcholine, and adenosine were compared in control and SAH rats. Additional studies using intracellular microelectrodes evaluated the effects of 4-AP and serotonin on Em of basilar arteries isolated from control and SAH rats.

Results—Baseline artery diameter was 236±5 µm in control rats and 220±7 µm in SAH rats (P<0.05). 4-AP, but not 3-AP, constricted the basilar artery in control rats, and responses to 4-AP were reduced in SAH rats. Constrictor responses to TEA or serotonin were unaffected by SAH. Vasodilator responses to acetylcholine were impaired in SAH rats, whereas responses to adenosine were not different. Resting Em was -81±3 mV in control arteries and -79±3 mV in SAH arteries. Both 4-AP and serotonin depolarized the basilar artery, but only 4-AP–induced depolarization was impaired in SAH arteries.

Conclusions—These data suggest that 4-AP induces cerebral vasoconstriction in vivo through smooth muscle depolarization due to inhibition of voltage-dependent K+ channels. Furthermore, function of these K+ channels may be selectively reduced in the basilar artery after SAH and thus could contribute to cerebral vascular dysfunction.

Editorial Comment

Zvonimir S. Katusic, MD, PhD, Guest Editor Vini G. Khurana, MD, Guest Editor

Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Koide, P. L. Penar, B. I. Tranmer, and G. C. Wellman
Heparin-binding EGF-like growth factor mediates oxyhemoglobin-induced suppression of voltage-dependent potassium channels in rabbit cerebral artery myocytes
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1750 - H1759.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. W. Britz, J. R. Meno, I.-S. Park, T. J. Abel, A. Chowdhary, T.-S. K. Nguyen, H. R. Winn, and A. C. Ngai
Time-Dependent Alterations in Functional and Pharmacological Arteriolar Reactivity After Subarachnoid Hemorrhage
Stroke, April 1, 2007; 38(4): 1329 - 1335.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Ishiguro, A. D. Morielli, K. Zvarova, B. I. Tranmer, P. L. Penar, and G. C. Wellman
Oxyhemoglobin-Induced Suppression of Voltage-Dependent K+ Channels in Cerebral Arteries by Enhanced Tyrosine Kinase Activity
Circ. Res., November 24, 2006; 99(11): 1252 - 1260.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. G. Sobey
Potassium Channel Function in Vascular Disease
Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 28 - 38.
[Abstract] [Full Text] [PDF]